Skadden Guides German Biopharm On €102.7M Placing
German biopharmaceutical business MorphoSys AG said Thursday it has raised €102.7 million ($112.7 million) from investors to support its ongoing clinical developments....To view the full article, register now.
Already a subscriber? Click here to view full article